ZJYL
NasdaqJin Medical International Ltd.
Technology · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Research view
Fundamentals · SEC EDGAR · FY 2025-09-30
Revenue & Earnings — fiscal year
$20.8M
2021
$19.2M
2022
$19.8M
2023
$23.5M
2024
$20.7M
2025
Snapshot
SEC EDGAR · FY 2025-09-30Revenue$20.7M
Net Income$1.4M
Gross Profit$6.0M
Oper Income$608,182
EPS (dil)$0.01
Rev/sh$0.13
FCF/sh$-0.02
Book/sh$0.19
Gross M29.2%
Oper M2.9%
Profit M6.7%
FCF M-18.0%
ROE4.7%
ROA2.6%
ROIC2.4%
R&D/Rev7.5%
Rev Y/Y-12.0%
Rev 3Y CAGR2.5%
EPS Y/Y-50.0%
EPS 3Y CAGR-20.6%
FCF 3Y CAGR—
Payout—
Div/sh—
Shs Chg Y/Y0%
Current Ratio1.86
Quick Ratio1.65
Debt/Eq—
Int Coverage—
Net Debt—
Total Debt—
Cash & Eq$7.5M
Total Assets$53.4M
Oper CF$2.9M
Capex$6.6M
Free CF$-3.7M
Buybacks—
Equity$29.6M
Liabilities$23.8M
Shs Outstand0.16B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $20.8M | $19.2M | $19.8M | $23.5M | $20.7M |
| Gross Profit | $6.4M | $6.2M | $6.8M | $9.5M | $6.0M |
| Operating Income | $2.6M | $2.1M | $2.9M | $3.6M | $608,182 |
| Net Income | $2.6M | $2.7M | $2.9M | $3.4M | $1.4M |
| Diluted EPS | $0.02 | $0.02 | $0.02 | $0.02 | $0.01 |
| Operating Cash Flow | $5.8M | $1.6M | $3.1M | $-1.2M | $2.9M |
| Free Cash Flow | $5.8M | $1.5M | $3.0M | $-1.4M | $-3.7M |
COMMUNITY · $ZJYL0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.